scispace - formally typeset
S

Sharon P. Andreoli

Researcher at Indiana University

Publications -  67
Citations -  4198

Sharon P. Andreoli is an academic researcher from Indiana University. The author has contributed to research in topics: Kidney disease & Dialysis. The author has an hindex of 27, co-authored 67 publications receiving 3819 citations. Previous affiliations of Sharon P. Andreoli include Boehringer Ingelheim.

Papers
More filters
Journal Article

K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease

Andrew S. Levey, +84 more
TL;DR: The purpose of the Executive Summary is to provide a "stand-alone" summary of the background, scope, methods, and key recommendations, as well as the complete text of the guideline statements.
Journal ArticleDOI

Exome Capture Reveals ZNF423 and CEP164 Mutations, Linking Renal Ciliopathies to DNA Damage Response Signaling

Moumita Chaki, +74 more
- 03 Aug 2012 - 
TL;DR: It is shown that knockdown of CEP164 or ZNF423 causes sensitivity to DNA damaging agents and that cep164 knockdown in zebrafish results in dysregulated DDR and an NPHP-RC phenotype, and these findings link degenerative diseases of the kidney and retina, disorders of increasing prevalence, to mechanisms of DDR.
Journal ArticleDOI

Aluminum Intoxication from Aluminum-Containing Phosphate Binders in Children with Azotemia Not Undergoing Dialysis

TL;DR: It is indicated that gastrointestinal absorption of aluminum can lead to aluminum intoxication in children with azotemia, and that infants may be particularly susceptible to this complication of therapy.
Journal ArticleDOI

Acute Renal Failure in the Newborn

TL;DR: In this article, the authors classified acute renal failure in newborns as prerenal, intrinsic renal disease including vascular insults, and obstructive uropathy, and showed that renal failure may have a prenatal onset in congenital diseases such as renal dysplasia with or without obstructive Uropathy.
Journal ArticleDOI

Acute kidney injury in children.

TL;DR: Improved understanding of the pathophysiology of AKI, early biomarkers ofAKI, and better classification of AKi are needed for the development of successful therapeutic strategies for the treatment of AK I.